JavaScript is disabled for your browser. Some features of this site may not work without it.
Statistics
Total Visits
| Views | |
|---|---|
| DOSE EQUIVALENCY AND EFFICACY OF BIOSIMILAR ERYTHROPOIETIN STIMULATING AGENTS: DATA FROM REAL CLINICAL PRACTICE | 79 |
Total Visits Per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| DOSE EQUIVALENCY AND EFFICACY OF BIOSIMILAR ERYTHROPOIETIN STIMULATING AGENTS: DATA FROM REAL CLINICAL PRACTICE | 1 | 3 | 7 | 1 | 2 | 4 | 5 |
File Visits
| Views | |
|---|---|
| prp2.594.pdf | 18 |
Top country views
| Views | |
|---|---|
| United States | 46 |
| Russia | 10 |
| Sweden | 5 |
| China | 4 |
| Iran | 3 |
| Australia | 1 |
| Canada | 1 |
| Kazakhstan | 1 |
| Romania | 1 |
| Turkey | 1 |
Top cities views
| Views | |
|---|---|
| Oakland | 19 |
| Louisville | 13 |
| Moscow | 9 |
| Boardman | 6 |
| Shanghai | 4 |
| Andover | 1 |
| Ann Arbor | 1 |
| Ashburn | 1 |
| Cebeci | 1 |
| Des Moines | 1 |
Submission guide